mRNA-based therapeutics: powerful and versatile tools to combat diseases
S Qin, X Tang, Y Chen, K Chen, N Fan… - Signal transduction and …, 2022 - nature.com
The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide
range of incurable diseases. Recent rapid advances in biotechnology and molecular …
range of incurable diseases. Recent rapid advances in biotechnology and molecular …
[HTML][HTML] Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy
S Prasad, E Kalafat, H Blakeway, R Townsend… - Nature …, 2022 - nature.com
Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …
COVID-19 vaccine development: milestones, lessons and prospects
M Li, H Wang, L Tian, Z Pang, Q Yang… - Signal transduction and …, 2022 - nature.com
With the constantly mutating of SARS-CoV-2 and the emergence of Variants of Concern
(VOC), the implementation of vaccination is critically important. Existing SARS-CoV-2 …
(VOC), the implementation of vaccination is critically important. Existing SARS-CoV-2 …
Maternal vaccination and risk of hospitalization for Covid-19 among infants
Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …
Association of BNT162b2 COVID-19 vaccination during pregnancy with neonatal and early infant outcomes
Importance Pregnant women were excluded from the BNT162b2 messenger RNA (mRNA)
COVID-19 vaccine (Pfizer-BioNTech) preauthorization trial. Therefore, observational data on …
COVID-19 vaccine (Pfizer-BioNTech) preauthorization trial. Therefore, observational data on …
Short‐term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID‐19 vaccine
S Bookstein Peretz, N Regev, L Novick… - … in Obstetrics & …, 2021 - Wiley Online Library
Objectives To determine the immunogenicity and reactogenicity of the Pfizer/BioNTech
BNT162b2 mRNA coronavirus disease 2019 (COVID‐19) vaccine among pregnant women …
BNT162b2 mRNA coronavirus disease 2019 (COVID‐19) vaccine among pregnant women …
Effects of COVID-19 and mRNA vaccines on human fertility
F Chen, S Zhu, Z Dai, L Hao, C Luan, Q Guo… - Human …, 2022 - academic.oup.com
ABSTRACT The coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has precipitated a global health crisis of …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has precipitated a global health crisis of …
COVID-19 vaccine acceptance of pregnant and lactating women (PLW) in Czechia: an analytical cross-sectional study
Pregnant and lactating women (PLW) represent a particular population subset with
increased susceptibility for COVID-19 morbidity and mortality, even though the evidence …
increased susceptibility for COVID-19 morbidity and mortality, even though the evidence …
Covid-19 vaccination in pregnancy
ML Badell, CM Dude, SA Rasmussen, DJ Jamieson - bmj, 2022 - bmj.com
Pregnancy is an independent risk factor for severe covid-19. Vaccination is the best way to
reduce the risk for SARS-CoV-2 infection and limit its morbidity and mortality. The current …
reduce the risk for SARS-CoV-2 infection and limit its morbidity and mortality. The current …
Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infection
Methods| The study included individuals who had received an mRNA COVID-19 vaccine in
pregnancy or were infected with SARS-CoV-2 at 20 to 32 weeks' gestation, had enrolled in a …
pregnancy or were infected with SARS-CoV-2 at 20 to 32 weeks' gestation, had enrolled in a …